Crunching the numbers. Responsibly.
All models are incomplete and must balance the need for experimental efficiency with the complexity of the natural world. To select and use models for the study of human disease, it is critical to understand what is of fundamental scientific importance and which limitations are thus of greatest concern. Here, we highlight key considerations for the design of research studies using mouse models of aspects of Alzheimer's disease for both mechanistic and proof-of-principle intervention studies. This primer considers mouse model choice, including the strengths and limitations of genetically altered, pathological aggregates injection, and human iPSC-chimera systems. We also review key principles of experimental design, husbandry, and technical considerations for the phenotyping of clinically disease-relevant features, with a focus on behavior and cognition.
Notably, no one AD preclinical model recapitulates all aspects of human disease, and thus no one model is suitable for all research questions.
model-by-model limitations support question-specific selection, although the narrative synthesis lacks a reported source-selection method
no one task or method is currently available to capture the full extent of all AD-relevant behavioural and cognitive changes. Therefore, a battery of complementary tasks is typically required
task-specific sensory, motor, motivational, and cognitive limitations support complementary testing without validating a particular battery
Derived from the full evaluation — not a separate score.
Strengths
Figure 1 connects hypothesis definition to model and procedure selection, confound assessment, feasibility, and data deposition. This integration provides a practical route through decisions otherwise distributed across specialist topics.
↳ Figure 1; Practical Guidance and Considerations
The discussion connects retinal mutations, sex differences, motivation, stress, and control-animal sourcing to the interpretation of behavioral outcomes. Limitations inform design decisions rather than appearing only as general cautions.
↳ Genetic Background and Sex; Memory Deficits; Potential Sensory and Motor Confounds; Identification and Evaluation of Procedural and Husbandry Confounds
The reporting section connects ARRIVE 2.0 and FAIR principles to metadata, machine-readable data, and repositories such as MOUSEBYTES. These links provide a concrete pathway for future comparison and synthesis.
↳ Analyse, Discuss, Contextualize, and Deposit Data
Limitations
The narrative review does not describe how sources were identified or selected. A dated AD-SOLES overview supplies a quantitative subset but does not establish the coverage or balance of the broader synthesis.
↳ Narrative-review sections throughout; Behavioral Phenotyping and Cognitive Testing Approaches
The paper calls predictive validity paramount and credits mouse models with antibody-development successes without engaging the clinical translation-failure record. This limits the balance of that part of the guidance.
↳ Choosing a Model; Modeling Alzheimer's Disease Using Mice
The Behavioral Phenotyping text includes Generic APP/PS1 among the top-five transgenic models summarized, whereas the Figure 2 legend substitutes APPSwe. The discrepancy needs clarification before the descriptive overview can be read consistently.
↳ Behavioral Phenotyping and Cognitive Testing Approaches; Table 1; Figure 2 legend
Figure 1 provides the organizing contribution by connecting model choice, measurement, confounds, feasibility, and reporting. The detailed model and task discussions support the qualified conclusions, but the lack of a source-selection account limits confidence in the completeness of the synthesis. The discussion of predictive validity is less balanced than the broader limitations analysis because it emphasizes antibody-development successes without engaging clinical translation failures. The localized Figure 2 model-set mismatch warrants clarification without undermining the central guidance.
Nabu’s assessment, alongside the field’s view.
Are you an author of this paper?
Sound3.4
Confidence highThe contribution is integration of model choice, phenotyping, husbandry, welfare, and reporting into a question-first workflow, supplemented by estimated model-use counts. It is a practical synthesis rather than a new validated framework or resolution of a contested uncertainty.
The argument connects biological and procedural limitations to experimental decisions and supports recommendations with extensive citations. The absence of a literature-identification or source-selection account limits confidence in how evidence was assembled and is explicitly priced into the score.
Figure 1 and the section structure make the decision sequence traceable, while the conclusions preserve scope qualifiers. Dense electrophysiology and in-cage passages and the Figure 2 model-set discrepancy limit followability and precision.
The review integrates species differences, genetic background, sex, welfare, and assay limitations into its recommendations. Its treatment of predictive validity is less complete because clinical translation failures are not engaged alongside the antibody-development success narrative.
Lower confidence on Contribution, Positioning — domain match limited.
Caveats4 of 4 checks
The model set described in the Behavioral Phenotyping text does not match the Figure 2 legend. This is a localized discrepancy in the descriptive literature overview, not a demonstrated failure of the central guidance.
Commercial and advisory interests are disclosed, including interests related to phenotyping platforms. No research-conduct concern is established for this narrative review, which reports no new animal or human experiment.
Flags: 1 declared / 5 total
235 references in manuscript 229 of 230 checkable references found in an index 5 are books, websites or datasets — counted, but not index-checkable
No retraction notice found in Retraction Watch.
Sources: Retraction Watch ✓
Where this paper’s evidence sits on the path from initial observation to real-world use.
The recommendations can inform current experimental planning, but the framework has not been tested as an intervention for improving reproducibility or translational prediction. Readiness therefore concerns consultation and design support rather than demonstrated operational benefit.
AI-generated, human-governed. Something look off? Contact us to request a review.